ALT FY 2016 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-50.8% YoY

Gross Profit

-$2M-38.1% margin

Operating Income

-$11M-215.4% margin

Net Income

$194M3706.4% margin

EPS (Diluted)

$-49.80

Cash Flow

Operating Cash Flow

$202M

Free Cash Flow

$201M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$225M

Total Liabilities

$205M

Stockholders' Equity

$19M

Cash & Equivalents

$154M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$11M	-50.8%
Gross Profit	-$2M	$6M	-135.7%
Operating Income	-$11M	-$3M	-231.0%
Net Income	$194M	-$3M	+5734.1%